iShares Biotechnology ETF (IBB) Stock Forecast, Price & News

iShares Biotechnology ETF (NASDAQ:IBB) Frequently Asked Questions

How often does iShares Biotechnology ETF pay dividends? What is the dividend yield for iShares Biotechnology ETF?

iShares Biotechnology ETF announced a quarterly dividend on Wednesday, March 23rd. Stockholders of record on Friday, March 25th will be paid a dividend of $0.118 per share on Wednesday, March 30th. This represents a $0.47 dividend on an annualized basis and a dividend yield of 0.41%. The ex-dividend date is Thursday, March 24th. This is a boost from iShares Biotechnology ETF's previous quarterly dividend of $0.04.
View iShares Biotechnology ETF's dividend history.

Is iShares Biotechnology ETF a good dividend stock?

iShares Biotechnology ETF pays an annual dividend of $0.31 per share and currently has a dividend yield of 0.27%.
View iShares Biotechnology ETF's dividend history.

When did iShares Biotechnology ETF's stock split? How did iShares Biotechnology ETF's stock split work?

iShares Biotechnology ETF shares split before market open on Friday, December 1st 2017. The 3-1 split was announced on Tuesday, November 7th 2017. The newly created shares were issued to shareholders after the closing bell on Thursday, November 30th 2017. An investor that had 100 shares of iShares Biotechnology ETF stock prior to the split would have 300 shares after the split.

Who are iShares Biotechnology ETF's key executives?

iShares Biotechnology ETF's management team includes the following people:

• George G. C. Parker Ph.D., Independent Chairman of the Board of Trustees
• Michael Arthur Latham, President, Trustee
• Jack Gee, Chief Financial Officer, Treasurer
• Geoffrey D. Flynn, Chief Operating Officer, Executive Vice President
• , Bio & Compensation - 
• Amy Schioldager, Executive Vice President
• Ira P. Shapiro, Vice President, Chief Legal Officer
• Matt Tucker, Vice President
• , Bio & Compensation - 
• Eilleen M. Clavere, Secretary
• Cecilia H. Herbert, Independent Trustee
• Charles A. Hurty, Independent Trustee

Who are some of iShares Biotechnology ETF's key competitors?

Some companies that are related to iShares Biotechnology ETF include SPDR Dow Jones Industrial Average ETF Trust (DIA), iShares MSCI Emerging Markets ETF (EEM), Consumer Discretionary Select Sector SPDR Fund (XLY), SPDR Bloomberg High Yield Bond ETF (JNK), SPDR Nuveen Barclays Short Term Municipal Bond ETF (SHM), SPDR Nuveen Barclays Municipal Bond ETF (TFI), DNP Select Income Fund (DNP), iShares MSCI Pacific ex Japan ETF (EPP), WisdomTree Emerging Markets High Dividend Fund (DEM), Direxion Daily Financial Bull 3X Shares (FAS), Nuveen Municipal Value Fund (NUV), Goldman Sachs BDC (GSBD), iShares MSCI Australia ETF (EWA), Adams Diversified Equity Fund (ADX) and The Gabelli Equity Trust (GAB).
View all of IBB's competitors.

What other stocks do shareholders of iShares Biotechnology ETF own?

Based on aggregate information from My MarketBeat watchlists, some companies that other iShares Biotechnology ETF investors own include NVIDIA (NVDA), Walt Disney (DIS), Netflix (NFLX), Alibaba Group (BABA), Tesla (TSLA), Cisco Systems (CSCO), Micron Technology (MU), Bank of America (BAC), Johnson & Johnson (JNJ) and PayPal (PYPL).

What is iShares Biotechnology ETF's stock symbol?

iShares Biotechnology ETF trades on the NASDAQ under the ticker symbol "IBB."

Who are iShares Biotechnology ETF's major shareholders?

iShares Biotechnology ETF's stock is owned by a number of institutional and retail investors. Top institutional shareholders include UBS Group AG (3.10%), Citigroup Inc. (3.03%), Goldman Sachs Group Inc. (2.42%), Royal Bank of Canada (1.97%), JPMorgan Chase & Co. (0.98%) and Commerce Bank (0.91%).

Which major investors are selling iShares Biotechnology ETF stock?

IBB stock was sold by a variety of institutional investors in the last quarter, including Healthcare of Ontario Pension Plan Trust Fund, Bank Julius Baer & Co. Ltd Zurich, Jane Street Group LLC, Alpha Cubed Investments LLC, Mmbg Investment Advisors CO., Cutler Group LP, Royal Bank of Canada, and Cetera Advisor Networks LLC.

Which major investors are buying iShares Biotechnology ETF stock?

IBB stock was acquired by a variety of institutional investors in the last quarter, including Goldman Sachs Group Inc., Citigroup Inc., Hackensack Meridian Health Inc., UBS Group AG, JPMorgan Chase & Co., Tredje AP fonden, Atria Wealth Solutions Inc., and First Interstate Bank.

How do I buy shares of iShares Biotechnology ETF?

Shares of IBB can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

What is iShares Biotechnology ETF's stock price today?

One share of IBB stock can currently be purchased for approximately $115.61.

How much money does iShares Biotechnology ETF make?

iShares Biotechnology ETF has a market capitalization of $7.55 billion.